DB
Therapeutic Areas
UbiVac Pipeline
| Drug | Indication | Phase |
|---|---|---|
| DPV-001 | Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) and other solid tumors | Phase 2 |
| Target Discovery Platform | Novel cancer antigen identification for multiple modalities | Discovery |